Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Hydrocortisone for Cognition in HIV-infected Women
NCT03237689Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2017
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in HIV-associated neurocognitive disorder (HAND) comparing Hydrocortisone with Placebo (2 arms). Primary endpoints: Hopkins Verbal Learning Test-Revised Total Learning at 28 days, Hopkins Verbal Learning Test-Revised Verbal Memory at 28 days and 2 more. Started Nov 2017; status: completed.
02
Drugs
hydrocortisone
03
Conditions
HIV-associated neurocognitive disorder (HAND)
Beyond the preview
Go deeper on NCT03237689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03237689.